OMER Q3 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$846M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+91.9% YoY

Gross Profit

$21M99.2% margin

Operating Income

-$5M-23.6% margin

Net Income

-$7M-34.5% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+26.3%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$126M

Total Liabilities

$116M

Stockholders' Equity

$9M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$11M	+91.9%
Gross Profit	$21M	$11M	+96.8%
Operating Income	-$5M	-$12M	+57.6%
Net Income	-$7M	-$14M	+46.4%